MedTrace Logo

The Importance of Sleep for Diabetes Associated Tasks and Outcomes

NCT05762783 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2024-04-18

No results posted yet for this study

Summary

Adolescents with type 1 diabetes (T1D) experience more disturbed sleep compared to their healthy peers, especially because they tend to spend less time in deep sleep, the most restoring part of sleep, potentially impacting diabetes management. Disturbed sleep may adversely affect diabetes management which requires day-to-day decision-making, emotional and behavioural regulation, attention, and planning. Despite a massive increase in new technology, more than 50% of adolescents do not reach their glycaemic target. Lack of sleep impairing diabetes management including blood glucose monitoring may play an important role in reaching the goal. For approximately 4000 children and adolescents in Denmark living with T1D, sleep disturbances may therefore account for short and long-term diabetes complications.

Our overall aims are to investigate: (1) If and how glycaemic variability (GV) influences sleep quality and sleep stages and (2) if and how poor sleep quality influences time-in-range (TIR), time-above-range (TAR) and time-below-range (TBR) the following day.

Conditions

  • type1diabetes
  • Sleep Disturbance

Sponsors & Collaborators

  • Danish Diabetes Academy

    collaborator OTHER

  • Danish Center for Sleep Medicine

    collaborator OTHER

  • University of Copenhagen

    collaborator OTHER

  • Herlev Hospital

    collaborator OTHER

  • Steno Diabetes Center Copenhagen

    lead OTHER

Principal Investigators

  • Jannet Svensson, Professor · Steno Diabetes Center Copenhagen

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-27
Primary Completion
2024-04-16
Completion
2024-04-16

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05762783 on ClinicalTrials.gov